DNA Friend might be a joke. But for DNA testing companies, it hits very close to home. » Read More
By: Jordan Novet
Bill Gates said that he spoke with Googlers on Monday in reference to a project related to ultrasound analysis. » Read More |
By: Thomas Franck
Shares of Tilray jumped after the bell Monday after it reported that its cannabis sales more than doubled over the last year. » Read More |
By: Christina Farr
Stanford's researchers talked about the study at the American College of Cardiology conference in New Orleans. » Read More |
The study adds to a growing body of research suggesting that sugary drinks can cause people to gain weight and possibly lead to a slew of health conditions, including obesity, Type 2 diabetes and heart disease.
Companies such as Bioness, Cefaly and Sana are developing technology to reduce pain -- and the need for addictive painkillers.
CNBC reviews the new Fitbit Inspire HR and Versa Lite, two affordable health trackers that work well but are very basic.
FDA chief Gottlieb leaves his post as the agency wages a pitched battle against teen smoking and tackles complex CBD regulations.
Nutrisystem's Dawn Zier is a businesswoman with a master's from MIT. Today she's a trailblazer in the $70 billion weight-loss market. How her engineering background led her to become recognized as one of the best CEOs in America.
Health experts say it's a smart move for Amazon, as it gets deeper into the health and medical space.
Signify Health acquired TAV Health, marking a rare acquisition of a start-up that is focusing on social determinants of health.
Former House Speaker John Boehner told CNBC on Friday that U.S. lawmakers are behind the times on cannabis legalization.
A single pill can contain 35 inactive ingredients, some of which may cause adverse reactions in patients.
Jim Cramer takes a look at some of the biggest headlines of the week that have rocked stocks on the market.
Walmart published an extensive case study this week on its efforts to improve health care for its employees.
A California jury on Wednesday ordered Johnson & Johnson to pay $29 million to a woman who alleged that asbestos in the company's talcum-powder-based products, including Johnson's Baby Powder, caused her mesothelioma.
Amazon, J.P. Morgan and Berkshire Hathaway are building a team to fix health care for their employees. Here's what we know.
Health and Human Services Secretary Alex Azar takes heat on Capitol Hill over some of the Trump administration's proposed cuts in health care.
Aurora's executive chairman tells CNBC that the company's partnership with Nelson Peltz is one of many relationships it hopes to foster.
Eric Topol just released a new book examining the role of artificial intelligence in medicine.
Get the best of CNBC in your inbox
Data also provided by 
